Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00175110 · ClinicalTrials.gov registry record · Phase 1
The Effect of Hibiscus Sabdariffa L. Tea on Blood Pressure
A Phase 1 study, sponsored by Tufts University.
- Completed
- Registry status
- Phase 1
- Development phase
- 66
- Enrollment target
NCT00175110: Completed Phase 1 study, sponsored by Tufts University.
NCT00175110 is a Phase 1 study that has completed, run by Tufts University. The registered enrollment target is 66 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (10% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00175110, a Phase 1 study, has completed, sponsored by Tufts University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 66 participants
- Enrollment target
Study Summary
The goal of this study is to find out whether the plant compounds present in Hibiscus sabdariffa, a plant commonly used in herbal tea blends and other beverages, will have a beneficial effect on blood pressure in people with mildly elevated blood pressure.
Interventions
- BEHAVIORAL herbal therapy/botanical therapy (Hibiscus sabdariffa)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Est. Completion | 2007-12 |
| Phase | Phase 1 |
What the finished NCT00175110 record still lists
NCT00175110 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (10% higher).
The record links to 0 conditions, and to 1 intervention - of which herbal therapy/botanical therapy (Hibiscus sabdariffa) is the first listed.
NCT00175110 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00175110 about?
NCT00175110 is a clinical study titled "The Effect of Hibiscus Sabdariffa L. Tea on Blood Pressure". The goal of this study is to find out whether the plant compounds present in Hibiscus sabdariffa, a plant commonly used in herbal tea blends and other beverages, will have a beneficial effect on blood pressure in people with mildly elevated blood pressure.
What is the current status of trial NCT00175110?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 66 participants. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00175110?
The interventions under investigation include: herbal therapy/botanical therapy (Hibiscus sabdariffa) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00175110?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00175110's enrollment target sits among peer trials
66 786th of 2000 higher than 1,203 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa